Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIO.B Bio-Rad Laboratories	$247.05	$250.89	$225.29 ▼ $359.22	$6.72B	0.76	44 shs	44 shs
FTV Fortive	$46.59 -2.8%	$61.17	$46.47 ▼ $83.32	$16.22B	1.09	3.90 million shs	4.97 million shs
TER Teradyne	$104.16 -3.0%	$89.70	$65.77 ▼ $144.16	$17.23B	1.72	4.51 million shs	4.81 million shs
VLTO Veralto	$104.59 -0.2%	$101.15	$83.86 ▼ $115.00	$26.01B	0.91	1.26 million shs	1.30 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIO.B Bio-Rad Laboratories	0.00%	-6.60%	-1.21%	+5.39%	-16.04%
FTV Fortive	-2.90%	-9.55%	-12.59%	-31.07%	-35.17%
TER Teradyne	-3.04%	+15.54%	+10.60%	+37.27%	-20.59%
VLTO Veralto	-0.16%	+1.17%	+1.69%	+9.43%	-1.89%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BIO.B Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FTV Fortive	4.9349 of 5 stars	4.2	5.0	1.7	2.5	1.9	2.5	2.5
TER Teradyne	4.7752 of 5 stars	3.3	3.0	1.7	3.4	3.8	1.7	2.5
VLTO Veralto	3.4486 of 5 stars	2.3	5.0	1.7	0.0	3.4	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIO.B Bio-Rad Laboratories	0.00	N/A	N/A	N/A
FTV Fortive	2.33	Hold	$65.86	41.35% Upside
TER Teradyne	2.56	Moderate Buy	$114.44	9.87% Upside
VLTO Veralto	2.56	Moderate Buy	$114.00	9.00% Upside

Current Analyst Ratings Breakdown

Latest BIO.B, VLTO, FTV, and TER Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2025	TER Teradyne	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$120.00 ➝ $130.00
7/31/2025	FTV Fortive	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$58.00 ➝ $56.00
7/31/2025	FTV Fortive	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$60.00 ➝ $55.00
7/31/2025	TER Teradyne	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$85.00 ➝ $100.00
7/31/2025	TER Teradyne	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$74.00 ➝ $100.00
7/30/2025	TER Teradyne	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell	$85.00
7/30/2025	TER Teradyne	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/30/2025	VLTO Veralto	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/30/2025	VLTO Veralto	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$104.00 ➝ $108.00
7/30/2025	VLTO Veralto	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$106.00 ➝ $112.00
7/30/2025	VLTO Veralto	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$116.00 ➝ $120.00

(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIO.B Bio-Rad Laboratories	$2.57B	2.62	$10.39 per share	23.77	$234.52 per share	1.05
FTV Fortive	$6.23B	2.53	$5.37 per share	8.68	$30.71 per share	1.52
TER Teradyne	$2.82B	5.93	$3.84 per share	27.13	$17.69 per share	5.89
VLTO Veralto	$5.19B	5.00	$3.88 per share	26.98	$10.72 per share	9.76

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIO.B Bio-Rad Laboratories	-$1.84B	$11.73	21.06	∞	N/A	12.50%	4.04%	2.84%	N/A
FTV Fortive	$832.90M	$2.28	20.99	10.64	3.02	13.62%	11.96%	7.08%	N/A
TER Teradyne	$542.37M	$2.89	36.04	20.42	2.25	16.59%	18.16%	13.80%	N/A
VLTO Veralto	$833M	$3.58	29.22	26.21	3.45	16.65%	41.45%	14.05%	N/A

Latest BIO.B, VLTO, FTV, and TER Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/31/2025	Q2 2025	BIO.B Bio-Rad Laboratories	N/A	$2.61	N/A	$11.67	N/A	N/A
7/30/2025	Q2 2025	FTV Fortive	$0.60	$0.58	-$0.02	$0.49	$1.54 billion	$1.52 billion
7/29/2025	Q2 2025	TER Teradyne	$0.54	$0.57	+$0.03	$0.49	$649.02 million	$651.80 million
7/28/2025	Q2 2025	VLTO Veralto	$0.89	$0.93	+$0.04	$0.89	$1.34 billion	$1.37 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIO.B Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
FTV Fortive	$0.32	0.69%	N/A	14.04%	2 Years
TER Teradyne	$0.48	0.46%	N/A	16.61%	1 Years
VLTO Veralto	$0.44	0.42%	N/A	12.29%	1 Years

Latest BIO.B, VLTO, FTV, and TER Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/15/2025	VLTO Veralto	quarterly	$0.11	0.44%	6/30/2025	6/30/2025	7/31/2025
5/8/2025	TER Teradyne	quarterly	$0.12	0.62%	5/22/2025	5/22/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIO.B Bio-Rad Laboratories	0.18	5.99	4.43
FTV Fortive	0.28	0.98	0.78
TER Teradyne	N/A	2.35	2.17
VLTO Veralto	1.00	2.32	1.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIO.B Bio-Rad Laboratories	0.01%
FTV Fortive	94.94%
TER Teradyne	99.77%
VLTO Veralto	91.28%

Insider Ownership

Company	Insider Ownership
BIO.B Bio-Rad Laboratories	28.38%
FTV Fortive	0.92%
TER Teradyne	0.16%
VLTO Veralto	0.36%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIO.B Bio-Rad Laboratories	8,200	27.21 million	19.49 million	Not Optionable
FTV Fortive	18,000	338.34 million	336.76 million	Optionable
TER Teradyne	6,500	160.42 million	160.16 million	Optionable
VLTO Veralto	17,000	248.16 million	247.27 million	Optionable

BIO.B, VLTO, FTV, and TER Headlines

Recent News About These Companies

Tredje AP fonden Lowers Position in Veralto Corporation (NYSE:VLTO)

August 1 at 7:50 AM | marketbeat.com

Banque Cantonale Vaudoise Takes Position in Veralto Corporation (NYSE:VLTO)

August 1 at 7:45 AM | marketbeat.com

Veralto (NYSE:VLTO) PT Set at $120.00 by Stifel Nicolaus

August 1 at 3:35 AM | americanbankingnews.com

Veralto (NYSE:VLTO) Price Target Raised to $112.00

August 1 at 3:35 AM | americanbankingnews.com

Analysts Have Made A Financial Statement On Veralto Corporation's (NYSE:VLTO) Second-Quarter Report

August 1 at 2:55 AM | finance.yahoo.com

Royal Bank Of Canada Issues Positive Forecast for Veralto (NYSE:VLTO) Stock Price

July 31 at 11:07 AM | marketbeat.com

Veralto (NYSE:VLTO) Stock Price Expected to Rise, Robert W. Baird Analyst Says

July 31 at 10:41 AM | marketbeat.com

Veralto (NYSE:VLTO) Given New $120.00 Price Target at Stifel Nicolaus

July 31 at 8:47 AM | marketbeat.com

Veralto upgraded to Outperform from Peer Perform at Wolfe Research

July 30 at 12:14 PM | msn.com

Eastern Bank Boosts Stock Position in Veralto Corporation (NYSE:VLTO)

July 30 at 5:59 AM | marketbeat.com

Essex Investment Management Co. LLC Buys Shares of 13,487 Veralto Corporation (NYSE:VLTO)

July 30 at 5:59 AM | marketbeat.com

Pacer Advisors Inc. Acquires 7,116 Shares of Veralto Corporation (NYSE:VLTO)

July 30 at 5:58 AM | marketbeat.com

Veralto (NYSE:VLTO) Releases Q3 2025 Earnings Guidance

July 29, 2025 | marketbeat.com

Veralto (NYSE:VLTO) Issues FY 2025 Earnings Guidance

July 29, 2025 | marketbeat.com

Veralto (NYSE:VLTO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

July 29, 2025 | marketbeat.com

Veralto Corporation (VLTO) Q2 2025 Earnings Call Transcript

July 29, 2025 | seekingalpha.com

Veralto Corporation 2025 Q2 - Results - Earnings Call Presentation

July 29, 2025 | seekingalpha.com

Veralto Q2 Earnings & Revenues Beat Estimates, Increase Y/Y

July 29, 2025 | zacks.com

Federated Hermes Inc. Acquires 29,802 Shares of Veralto Corporation (NYSE:VLTO)

July 29, 2025 | marketbeat.com

Zurcher Kantonalbank Zurich Cantonalbank Has $20.06 Million Position in Veralto Corporation (NYSE:VLTO)

July 29, 2025 | marketbeat.com

TD Asset Management Inc Raises Stock Position in Veralto Corporation (NYSE:VLTO)

July 29, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BIO.B, VLTO, FTV, and TER Company Descriptions

Bio-Rad Laboratories NYSE:BIO.B

$247.05 0.00 (0.00%)

As of 07/31/2025

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Fortive NYSE:FTV

$46.59 -1.34 (-2.80%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$47.02 +0.42 (+0.91%)

As of 08/1/2025 07:47 PM Eastern

Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Teradyne NASDAQ:TER

$104.16 -3.27 (-3.04%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$103.80 -0.36 (-0.35%)

As of 08/1/2025 07:57 PM Eastern

Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications. This segment also provides FLEX test platform systems; J750 test system to address the volume semiconductor devices, including microcontrollers; Magnum platform that tests memory devices, such as flash memory and DRAM; and ETS platform for semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets. It serves integrated device manufacturers that integrate the fabrication of silicon wafers into their business; fabless companies that outsource the manufacturing of silicon wafers; foundries; and semiconductor assembly and test providers. The System Test segment offers defense/aerospace test instrumentation and systems; storage and system level test systems; and circuit-board test and inspection systems. The Wireless Test segment provides wireless test solutions for silicon validation, wireless module manufacturing, and wireless end device manufacturing under the LitePoint brand. This segment also offers IQxel-MX and IQxel-MW7G series products for edge measurement performance in the manufacturing of connectivity products; IQxstream-5G and IQgig-5G family products to support 4G and 5G technologies; and IQgig-UWB+ for certification and manufacturing test support for ultra wideband products. The Robotics segment provides collaborative robotic arms, autonomous mobile robots, and advanced robotic control software for manufacturing, logistics, and industrial customers. The company was incorporated in 1960 and is headquartered in North Reading, Massachusetts.

Veralto NYSE:VLTO

$104.59 -0.24 (-0.23%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$104.74 +0.14 (+0.14%)

As of 08/1/2025 04:32 PM Eastern

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands. This segment provides water solutions, including chemical reagents, services, and digital solutions. The PQI segment offers inline printing solutions for products and packaging with marking and coding systems; marking and coding for packaged goods and related consumables; design software and imaging systems for the creation of new packaging designs; color management solutions for printed packages and consumer and industrial products; color standard services for the design industry; and a software solution that provides digital asset management, marketing resource management, and product information management. This segment sells its products and services through the Videojet, Linx, Esko, X-Rite, and Pantone brands to regulated industries, including municipal utilities, food and beverage, pharmaceutical, and industrials. The company was formerly known as DH EAS Holding Corp. and changed its name to Veralto Corporation in February 2023. Veralto Corporation was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time